Immatics (NasdaqCM:IMTX) Update / Briefing Transcript

Immatics (NasdaqCM:IMTX) Update / Briefing November 12, 2025 08:30 AM ET Company ParticipantsGraig Suvannavejh - Managing DirectorCarsten Reinhardt - Chief Development OfficerJames Shin - Director of Biopharma Equity ResearchJonathan Chang - Senior Managing DirectorHarpreet Singh - CEOConference Call ParticipantsPaul Jeng - Research AnalystEric Schmidt - Biotechnology AnalystClara Dong - VP and Equity Research Analyst in BiotechnologyNone - AnalystSebastiaan van der Schoot - Equity Research Analyst of Life ...